Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

被引:71
作者
Davidson, B [1 ]
Givant-Horwitz, V
Lazarovici, P
Risberg, B
Nesland, JM
Trope, CG
Schaefer, E
Reich, R
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
[2] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmacol & Expt Therapeut, Jerusalem, Israel
[3] QCB, Signal Transduct Res & Dev, Hopkinton, MA USA
[4] Univ Oslo, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0310 Oslo, Norway
[5] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91905 Jerusalem, Israel
关键词
effusions; EMMPRIN; matrix metalloproteinases; mitogen-activated protein kinases; ovarian carcinoma;
D O I
10.1023/A:1027347932543
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Activation or suppression of intracellular signaling via the mitogen-activated protein kinase (MAPK) family has been linked to expression of matrix metalloproteinases (MMP) in experimental models, but this association has not been demonstrated in clinical material. The objective of this study was to investigate the possible association between expression and activity of MMP, expression of the MMP inducer EMMPRIN, and the expression (level) and phosphorylation status (activity) of the extracellular-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK) and high osmolarity glycerol response kinase (p38) in effusions from patients diagnosed with serous ovarian carcinoma. MAPK level and activity were studied in 55 effusions using immunoblotting. MMP-1, MMP-2, MMP-9 and EMMPRIN expression was studied using immunocytochemistry (ICC) and mRNA in situ hybridization (ISH). The gelatinolytic activity of MMP-2 and MMP-9 was measured by zymography. ERK and phospho-ERK (p-ERK) were detected in 54/55 (98%) and 50/55 (91%) specimens, respectively. JNK and p-JNK were detected in 53/55 (96%) and 38/55 (69%) specimens, respectively. p38 was expressed in 54/55 (98%) specimens, and its phosphorylated form was found in 51/55 (92%). MMP-2 mRNA expression (P = 0.048), protein expression (P = 0.046) and gelatinolytic activity (P = 0.039) correlated with ERK phosphorylative activity. MMP-2 activity also correlated with p38 activity (P = 0.017). MMP-9 protein expression correlated with phosphorylation of p38 (P = 0.046), but enzyme activity showed inverse relationship with both p-ERK (P = 0.05) and p-p38 (P = 0.033) expression. EMMPRIN expression correlated with MMP-1 (P < 0.001), MMP-2 ( P = 0.042) and MMP-9 (P = 0.029) expression, as well as with ERK activity ( P = 0.001). Our results present the first evidence of a possible link between MAPK signaling and MMP expression and activity in vivo. These data may expand our understanding regarding the mechanisms by which MMP synthesis is regulated in effusions and possibly affect treatment strategies for this form of malignancy.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 55 条
[1]   Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications [J].
Berner, HS ;
Davidson, B ;
Berner, A ;
Risberg, B ;
Kristensen, GB ;
Trope, CG ;
Van de Putte, G ;
Nesland, JM .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) :197-202
[2]   Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1 [J].
Brauchle, M ;
Glück, D ;
Di Padova, F ;
Han, JH ;
Gram, H .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (01) :135-144
[3]   Inhibition of epidermal growth factor-mediated ERK1/2 activation by in situ electroporation of nonpermeant [(alkylamino)methyl]acrylophenone derivatives [J].
Brownell, HL ;
Lydon, NB ;
Schaefer, E ;
Roberts, TM ;
Raptis, L .
DNA AND CELL BIOLOGY, 1998, 17 (03) :265-274
[4]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[5]   Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase [J].
da Rocha, AB ;
Mans, DRA ;
Lenz, G ;
Fernandes, AK ;
de Lima, C ;
Monteiro, VF ;
Gonçalves, D ;
Moreira, JCF ;
Brunetto, AL ;
Rodnight, R ;
Schwartsmann, G .
PATHOBIOLOGY, 2000, 68 (03) :113-123
[6]   Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma:: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions [J].
Davidson, B ;
Berner, A ;
Nesland, JM ;
Risberg, B ;
Kristensen, GB ;
Tropé, CG ;
Bryne, M .
HUMAN PATHOLOGY, 2000, 31 (09) :1081-1087
[7]   Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies -: Evaluation of five epithelial markers [J].
Davidson, B ;
Risberg, B ;
Kristensen, G ;
Kvalheim, G ;
Emilsen, E ;
Bjåmer, A ;
Berner, A .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (01) :43-49
[8]   Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels [J].
Davidson, B ;
Reich, R ;
Berner, A ;
Givant-Horwitz, V ;
Goldberg, I ;
Risberg, B ;
Kristensen, GB ;
Trope, CG ;
Bryne, M ;
Kopolovic, J ;
Nesland, JM .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (16) :2040-2049
[9]   αv- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients [J].
Davidson, B ;
Goldberg, I ;
Reich, R ;
Tell, L ;
Dong, HP ;
Trope, CG ;
Risberg, B ;
Kopolovic, J .
GYNECOLOGIC ONCOLOGY, 2003, 90 (02) :248-257
[10]   EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma [J].
Davidson, B ;
Goldberg, I ;
Berner, A ;
Kristensen, GB ;
Reich, R .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (02) :161-169